TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Danish Trial of Beta Blocker Treatment After Myocardial Infarction Without Reduced Ejection Fraction (DANBLOCK)
Brief Summary: To determine whether long-term treatment with oral betablocker therapy after myocardial infarction in patient with no heart failure reduces the composite outcome of recurrent MI, all-cause mortality, revascularisation with percutaneous coronary intervention or coronary artery bypass graft, ischemic stroke, incident heart failure, or malignant ventricular arrhythmia including resuscitated cardiac arrest.


Options:
A: Arm Label: Beta blocker treatment; Type: EXPERIMENTAL; Interventions: Drug: Metoprolol Succinate, Drug: Bisoprolol, Drug: Carvedilol, Drug: Nebivolol | Arm Label: No beta blocker treatment; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: Metoprolol Succinate; Assigned to Arm(s): Beta blocker treatment | Intervention Type: DRUG; Name: Bisoprolol; Assigned to Arm(s): Beta blocker treatment | Intervention Type: DRUG; Name: Carvedilol; Assigned to Arm(s): Beta blocker treatment | Intervention Type: DRUG; Name: Nebivolol; Assigned to Arm(s): Beta blocker treatment
B: Intervention Type: DRUG; Name: clopidogrel (SR25990); Assigned to Arm(s): N/A
C: Arm Label: No Beta blocker and no ACEI/ARB; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Beta blocker and ACEI/ARB; Type: EXPERIMENTAL; Interventions: Drug: Beta blocker, Drug: ACEI, Drug: ARB | Arm Label: Beta blocker alone; Type: EXPERIMENTAL; Interventions: Drug: Beta blocker | Arm Label: ACEI/ARB alone; Type: EXPERIMENTAL; Interventions: Drug: ACEI, Drug: ARB | Intervention Type: DRUG; Name: Beta blocker; Assigned to Arm(s): Beta blocker alone, Beta blocker and ACEI/ARB | Intervention Type: DRUG; Name: ACEI; Assigned to Arm(s): ACEI/ARB alone, Beta blocker and ACEI/ARB | Intervention Type: DRUG; Name: ARB; Assigned to Arm(s): ACEI/ARB alone, Beta blocker and ACEI/ARB
D: Arm Label: A; Type: EXPERIMENTAL; Interventions: Drug: Metoprolol controlled release (CR) | Arm Label: B; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Metoprolol controlled release (CR); Assigned to Arm(s): A | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): B

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Evaluation of Influence of Home Physical Training Program and Respiratory Rehabilitation on Quality of Life, Body Composition, and Function of Respiratory Muscles in Patients With Primary PAH, HFREF and IHD
Brief Summary: The aim of the study is to evaluate the influence of physical training and respiratory rehabilitation performed by patients at home on quality of life, symptoms, physical endurance, force of respiratory and skeletal muscles and body mass composition in patients with pulmonary arterial hypertension (PAH) or left ventricular heart failure with reduced ejection fraction - HFREF), or ischemic heart disease and evaluation the number of stem cells, natural lymphoid cells and distribution of subpopulations of monocytes (including proangiogenic monocytes) in examined persons and evaluation of theirs eventual influence of the course of disease.


Options:
A: Arm Label: Training Group; Type: ACTIVE_COMPARATOR; Interventions: Other: Upper extremity aerobic exercise training | Arm Label: Control Group; Type: SHAM_COMPARATOR; Interventions: Other: Alternative upper extremity exercises | Intervention Type: OTHER; Name: Upper extremity aerobic exercise training; Assigned to Arm(s): Training Group | Intervention Type: OTHER; Name: Alternative upper extremity exercises; Assigned to Arm(s): Control Group
B: Arm Label: Patients with PAH; Type: EXPERIMENTAL; Interventions: Other: home cardiac rehabilitation and respiratory rehabilitation | Arm Label: Patients with HFREF; Type: EXPERIMENTAL; Interventions: Other: home cardiac rehabilitation and respiratory rehabilitation | Arm Label: Patients with IHD; Type: EXPERIMENTAL; Interventions: Other: home cardiac rehabilitation and respiratory rehabilitation | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: home cardiac rehabilitation and respiratory rehabilitation; Assigned to Arm(s): Patients with HFREF, Patients with IHD, Patients with PAH
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Other: Aerobic exercise | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Other: Aerobic exercise | Intervention Type: OTHER; Name: Aerobic exercise; Assigned to Arm(s): 1, 2
D: Arm Label: exercise training group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: exercise training | Arm Label: Control group without exercise training; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: exercise training; Assigned to Arm(s): exercise training group

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Patiromer Efficacy to Reduce Episodic Hyperkalemia in End Stage Renal Disease Patients Treated With Hemodialysis (PEARL-HD)
Brief Summary: The purpose of this study is to determine whether once-daily dosing of patiromer will reduce the frequency of hyperkalemic episodes in ESRD (end stage renal disease) study participants who receive conventional hemodialysis (HD). The study objective is to determine if patiromer administered orally once a day with breakfast or lunch will reduce episodes of hyperkalemia in ESRD study participants who receive thrice-weekly HD.


Options:
A: Arm Label: Sodium Zirconium Cyclosilicate (ZS) 5g; Type: EXPERIMENTAL; Interventions: Drug: Sodium Zirconium Cyclosilicate (ZS) 5g | Arm Label: Sodium Zirconium Cyclosilicate (ZS) 10g; Type: EXPERIMENTAL; Interventions: Drug: Sodium Zirconium Cyclosilicate (ZS) 10g | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Sodium Zirconium Cyclosilicate (ZS) 5g; Assigned to Arm(s): Sodium Zirconium Cyclosilicate (ZS) 5g | Intervention Type: DRUG; Name: Sodium Zirconium Cyclosilicate (ZS) 10g; Assigned to Arm(s): Sodium Zirconium Cyclosilicate (ZS) 10g | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: Patiromer Oral Powder Product; Type: EXPERIMENTAL; Interventions: Drug: Patiromer Oral Powder Product | Arm Label: Usual care arm; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: Patiromer Oral Powder Product; Assigned to Arm(s): Patiromer Oral Powder Product
C: Arm Label: Sodium Zirconium Cyclosilicate (ZS); Type: EXPERIMENTAL; Interventions: Drug: Sodium Zirconium Cyclosilicate (ZS) | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo | Intervention Type: DRUG; Name: Sodium Zirconium Cyclosilicate (ZS); Assigned to Arm(s): Sodium Zirconium Cyclosilicate (ZS)
D: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: Zirconium silicate (ZS); Type: EXPERIMENTAL; Interventions: Drug: Zirconium silicate (ZS) | Intervention Type: DRUG; Name: Zirconium silicate (ZS); Assigned to Arm(s): Zirconium silicate (ZS) | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Brief Mindfulness Meditation Course to Reduce Stress in Healthcare Professionals and Trainees: A Randomized Clinical Trial
Brief Summary: Stress among healthcare professionals is well documented. Untreated stress can lead to anxiety, depression, substance use, and suicide. The use of mindfulness-based programs to reduce stress and enhance wellbeing, among health care professionals, has increased with promising results. Typical mindfulness-based programs are 30 hours in length across 9 sessions. The purpose of this study is to assess the effectiveness of a shorter and more practical program that could be offered during work hours to health care professionals at the NIH Clinical Center. The program will be delivered in five weekly 1.5 hour sessions.


Options:
A: Arm Label: dialectical behavior therapy; Type: EXPERIMENTAL; Interventions: Behavioral: Dialectical behavior therapy | Arm Label: treatment as usual; Type: PLACEBO_COMPARATOR; Interventions: Other: Treatment as Usual: any other drug or psychotherapy offered to participants, except DBT | Arm Label: Receiving no treatment at all; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Dialectical behavior therapy; Assigned to Arm(s): dialectical behavior therapy | Intervention Type: OTHER; Name: Treatment as Usual: any other drug or psychotherapy offered to participants, except DBT; Assigned to Arm(s): treatment as usual
B: Arm Label: Resiliency Training; Type: EXPERIMENTAL; Interventions: Behavioral: Disaster Worker Resiliency Training | Arm Label: Waitlist; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Disaster Worker Resiliency Training; Assigned to Arm(s): Resiliency Training
C: Arm Label: A; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: General Psychiatric Management | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Behavioral: Dialectical Behaviour Therapy | Intervention Type: BEHAVIORAL; Name: General Psychiatric Management; Assigned to Arm(s): A | Intervention Type: BEHAVIORAL; Name: Dialectical Behaviour Therapy; Assigned to Arm(s): 2
D: Arm Label: Mindfulness-based self-care; Type: EXPERIMENTAL; Interventions: Behavioral: Mindfulness-based self care | Arm Label: Life as usual control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Mindfulness-based self care; Assigned to Arm(s): Mindfulness-based self-care

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Brief Mindfulness Meditation Course to Reduce Stress in Healthcare Professionals and Trainees: A Randomized Clinical Trial
Brief Summary: Stress among healthcare professionals is well documented. Untreated stress can lead to anxiety, depression, substance use, and suicide. The use of mindfulness-based programs to reduce stress and enhance wellbeing, among health care professionals, has increased with promising results. Typical mindfulness-based programs are 30 hours in length across 9 sessions. The purpose of this study is to assess the effectiveness of a shorter and more practical program that could be offered during work hours to health care professionals at the NIH Clinical Center. The program will be delivered in five weekly 1.5 hour sessions.


Options:
A: Arm Label: Resiliency Training; Type: EXPERIMENTAL; Interventions: Behavioral: Disaster Worker Resiliency Training | Arm Label: Waitlist; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Disaster Worker Resiliency Training; Assigned to Arm(s): Resiliency Training
B: Arm Label: Active ABMT8; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Active ABMT8 | Arm Label: Active ABMT4; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Active ABMT4 | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Placebo | Intervention Type: BEHAVIORAL; Name: Active ABMT8; Assigned to Arm(s): Active ABMT8 | Intervention Type: BEHAVIORAL; Name: Active ABMT4; Assigned to Arm(s): Active ABMT4 | Intervention Type: BEHAVIORAL; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: Sudarshan Kroya Yoga (SKY); Type: EXPERIMENTAL; Interventions: Other: Sudarshan Kriya Yoga (SKY) | Arm Label: Health Enhancement Program (HEP); Type: ACTIVE_COMPARATOR; Interventions: Other: Health Enhancement Program | Intervention Type: OTHER; Name: Sudarshan Kriya Yoga (SKY); Assigned to Arm(s): Sudarshan Kroya Yoga (SKY) | Intervention Type: OTHER; Name: Health Enhancement Program; Assigned to Arm(s): Health Enhancement Program (HEP)
D: Arm Label: Mindfulness-based self-care; Type: EXPERIMENTAL; Interventions: Behavioral: Mindfulness-based self care | Arm Label: Life as usual control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Mindfulness-based self care; Assigned to Arm(s): Mindfulness-based self-care

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Mindfulness-Based Resilience Training for Aggression, Health, and Stress Among Law Enforcement Officers
Brief Summary: Law enforcement officers (LEOs) are exposed to significant stressors, elevating their risk for aggression and excessive use of force, as well as mental health consequences, including post-traumatic stress disorder, burnout, alcohol misuse, depression, and suicide. The proposed study will identify, optimize and refine best clinical and research practices across two sites to ensure success in a future multisite efficacy trial assessing preventative effects of Mindfulness-Based Resilience Training on physiological, behavioral, and psychological outcomes.


Options:
A: Arm Label: Mindfulness-Based Resilience Training; Type: EXPERIMENTAL; Interventions: Behavioral: Mindfulness-Based Resilience Training | Arm Label: Stress Management Education; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Stress Management Education | Arm Label: No Intervention Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Mindfulness-Based Resilience Training; Assigned to Arm(s): Mindfulness-Based Resilience Training | Intervention Type: BEHAVIORAL; Name: Stress Management Education; Assigned to Arm(s): Stress Management Education
B: Arm Label: Group therapy; Type: EXPERIMENTAL; Interventions: Behavioral: Manualized Therapy | Arm Label: Control Group; Type: OTHER; Interventions: Behavioral: Control Group | Intervention Type: BEHAVIORAL; Name: Manualized Therapy; Assigned to Arm(s): Group therapy | Intervention Type: BEHAVIORAL; Name: Control Group; Assigned to Arm(s): Control Group
C: Arm Label: Intervention Group; Type: OTHER; Interventions: Behavioral: Internet-Based Mindfulness Program - Stress Free Now for Healers | Arm Label: Active Control Group; Type: OTHER; Interventions: Behavioral: Active Control Group - Relaxing Music | Intervention Type: BEHAVIORAL; Name: Internet-Based Mindfulness Program - Stress Free Now for Healers; Assigned to Arm(s): Intervention Group | Intervention Type: BEHAVIORAL; Name: Active Control Group - Relaxing Music; Assigned to Arm(s): Active Control Group
D: Arm Label: Active ABMT8; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Active ABMT8 | Arm Label: Active ABMT4; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Active ABMT4 | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Placebo | Intervention Type: BEHAVIORAL; Name: Active ABMT8; Assigned to Arm(s): Active ABMT8 | Intervention Type: BEHAVIORAL; Name: Active ABMT4; Assigned to Arm(s): Active ABMT4 | Intervention Type: BEHAVIORAL; Name: Placebo; Assigned to Arm(s): Placebo

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Non-interventional Cross-sectional Study to Capture the Prevalence of Cardiovascular Disease in Patients With Type 2 Diabetes in Selected Countries in Europe
Brief Summary: The purpose of the study is to register the occurrence of cardiovascular disease among type 2 diabetes (T2DM) patients across five selected countries in Europe. Participants will be asked to give information about their health. Participants will continue their normal way of life and will not get any medication other than what has been prescribed to them by their doctor. Participants' participation will be one day/one visit at study doctor. The study will last for about 3 months in total.


Options:
A: Arm Label: 1; Type: N/A; Interventions: N/A | Arm Label: 2; Type: N/A; Interventions: N/A
B: Arm Label: Telemedicine system; Type: EXPERIMENTAL; Interventions: Device: Home telehealth system | Arm Label: Usual care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Home telehealth system; Assigned to Arm(s): Telemedicine system
C: Arm Label: Advanced care; Type: OTHER; Interventions: Other: Advanced Care | Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Advanced Care; Assigned to Arm(s): Advanced care
D: Arm Label: T2DM patients seen in routine practice; Type: N/A; Interventions: Other: No treatment given | Intervention Type: OTHER; Name: No treatment given; Assigned to Arm(s): T2DM patients seen in routine practice

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Use of an Innovative Device for Therapeutic Adherence in Pediatric Asthma
Brief Summary: The management of chronic diseases requires a constant monitoring of treatment adherence, in order to obtain an optimal disease control. However, this is often difficult to achieve, especially in pediatric age.

In this sense, for asthmatic patients treated by Symbicort Turbohaler, "AstraZeneca" developed the "Turbo+", an electronic device attached to the Turbohaler, which allows to feel whether the patient does the inhalation, and to register it on a specific application.

The present randomized trial aims to compare the treatment adherence between asthmatic children/adolescents aged 6-17 years treated with Symbicort Turbohaler plus Turbo+ or Symbicort Turbohaler without Turbo+.


Options:
A: Arm Label: Feedback and alarms; Type: EXPERIMENTAL; Interventions: Device: Activated Smartinhaler or Smartturbo, Other: Feedback of adherence data | Arm Label: No feedback or alarms; Type: ACTIVE_COMPARATOR; Interventions: Device: Deactivated Smartinhaler or Smartturbo | Intervention Type: DEVICE; Name: Activated Smartinhaler or Smartturbo; Assigned to Arm(s): Feedback and alarms | Intervention Type: OTHER; Name: Feedback of adherence data; Assigned to Arm(s): Feedback and alarms | Intervention Type: DEVICE; Name: Deactivated Smartinhaler or Smartturbo; Assigned to Arm(s): No feedback or alarms
B: Arm Label: Paper Asthma Action Plan; Type: EXPERIMENTAL; Interventions: Other: Paper Asthma Action Plan | Arm Label: Mobile Phone; Type: EXPERIMENTAL; Interventions: Device: Mobile Phone | Intervention Type: OTHER; Name: Paper Asthma Action Plan; Assigned to Arm(s): Paper Asthma Action Plan | Intervention Type: DEVICE; Name: Mobile Phone; Assigned to Arm(s): Mobile Phone
C: Arm Label: Azithromycin; Type: EXPERIMENTAL; Interventions: Drug: Azithromycin 250 mg | Arm Label: placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Azithromycin 250 mg; Assigned to Arm(s): Azithromycin | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): placebo
D: Arm Label: Symbicort Turbohaler plus Turbo+; Type: EXPERIMENTAL; Interventions: Device: Symbicort Turbohaler plus Turbo+ | Arm Label: Symbicort Turbohaler without Turbo+; Type: ACTIVE_COMPARATOR; Interventions: Drug: Symbicort Turbohaler without Turbo+ | Intervention Type: DEVICE; Name: Symbicort Turbohaler plus Turbo+; Assigned to Arm(s): Symbicort Turbohaler plus Turbo+ | Intervention Type: DRUG; Name: Symbicort Turbohaler without Turbo+; Assigned to Arm(s): Symbicort Turbohaler without Turbo+

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Study of Some Pharmacological and Biochemical Effects of Gum Arabic Supplementation to Hemodilaysis Patients
Brief Summary: Gum Arabic is a naturally produced gummy exudate from Acacia Senegal tree. It's a complex polysaccharide with proven prebiotic properties. Through its effect on intestinal bacteria, it's expected to reduce systemic levels of toxic bacterial metabolites and reduce inflammatory markers.By increasing fecal bacteria mass it's also expected to reduce blood urea level. These changes are potentially beneficial to hemodialysis patients who suffer from disturbed intestinal flora and a chronic inflammatory status. The investigators hypothesize that supplementing the diet of hemodialysis patients with Gum Arabic for four weeks would reduce inflammatory markers, increase total anti-oxidant capacity and reduce blood urea concentration.


Options:
A: Arm Label: A; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Gum Arabic | Arm Label: B; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Arm Label: C; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Gum Arabic | Arm Label: D; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Gum Arabic | Intervention Type: DIETARY_SUPPLEMENT; Name: Gum Arabic; Assigned to Arm(s): A, C, D | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): B
B: Arm Label: Fructooligosaccharide; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Fructooligosaccharide | Arm Label: Maltodextrin; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Maltodextrin | Intervention Type: DIETARY_SUPPLEMENT; Name: Fructooligosaccharide; Assigned to Arm(s): Fructooligosaccharide | Intervention Type: DIETARY_SUPPLEMENT; Name: Maltodextrin; Assigned to Arm(s): Maltodextrin
C: Arm Label: probiotic soy milk; Type: EXPERIMENTAL; Interventions: Dietary Supplement: probiotic soy milk | Arm Label: soy milk; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: probiotic soy milk | Intervention Type: DIETARY_SUPPLEMENT; Name: probiotic soy milk; Assigned to Arm(s): probiotic soy milk, soy milk
D: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Placebo | Arm Label: Probiotic packet; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Probiotic packet | Intervention Type: DIETARY_SUPPLEMENT; Name: Probiotic packet; Assigned to Arm(s): Probiotic packet | Intervention Type: DIETARY_SUPPLEMENT; Name: Placebo; Assigned to Arm(s): Placebo

Answer: A